Correlation Between Pure Cycle and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Pure Cycle and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pure Cycle and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pure Cycle and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on Pure Cycle and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pure Cycle with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pure Cycle and Telomir Pharmaceuticals,.

Diversification Opportunities for Pure Cycle and Telomir Pharmaceuticals,

0.23

Correlation Coefficient

Pure Cycle  Telomir Pharmaceuticals,

Modest diversification

The 3 months correlation between Pure and Telomir is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pure Cycle and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and Pure Cycle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pure Cycle are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of Pure Cycle i.e., Pure Cycle and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Pure Cycle and Telomir Pharmaceuticals,

Given the investment horizon of 90 days Pure Cycle is expected to under-perform the Telomir Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Pure Cycle is 3.42 times less risky than Telomir Pharmaceuticals,. The stock trades about -0.45 of its potential returns per unit of risk. The Telomir Pharmaceuticals, Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  497.00  in Telomir Pharmaceuticals, Common on October 25, 2024 and sell it today you would lose (22.50) from holding Telomir Pharmaceuticals, Common or give up 4.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pure Cycle  vs.  Telomir Pharmaceuticals, Commo

Pure Cycle

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pure Cycle are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Pure Cycle may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting essential indicators, Telomir Pharmaceuticals, displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pure Cycle and Telomir Pharmaceuticals,

The main advantage of trading using opposite Pure Cycle and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pure Cycle position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind Pure Cycle and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.